A public-private partnership will fund clinical trials of vaccines that could prevent cancer recurrence
Oct 29
1 min read
WSJ Pro
March 17, 2026 11:15 am ET

Momentum is building for therapeutic cancer vaccines. Following the global think tank convened by the Cancer Vaccine Coalition and AACR, HHS, through the National Cancer Institute, is advancing a proposed $200 million public-private partnership to fund clinical trials of vaccines that could help prevent cancer recurrence. "Beating Cancer Daily" Podcast Host and CVC board member, Saranne Rothberg, and CVC Founder Kristen Dahlgren among the patient advocates and survivors working to bring this promising science closer to patients.
Read more here: https://www.wsj.com/articles/hhs-has-a-potential-solution-for-cancers-that-keep-coming-back-vaccines-23e7175c




Comments